Observational Evaluation of Atopic Dermatitis in Pediatric Patients

Not Recruiting

11 years or below

All

Phase N/A

1860 participants needed

Study Overview

Primary Objectives:

To describe the characteristics of pediatric patients with moderate to severe atopic dermatitis (AD) whose disease is not adequately controlled with topical therapies or when those therapies are not medically advisable.
To evaluate the time-course of AD and selected atopic comorbidities.

Secondary Objectives:

To characterize disease burden and unmet need.
To describe real-world treatment patterns (eg, dosing regimens, treatment duration, and reasons for discontinuation and/or switching).
To document the real-world effectiveness and safety of treatments.

The study duration is 120 months.

You may be eligible for this study if you meet the following criteria:

Inclusion criteria:

Patients with moderate to severe AD, according to the Investigator's assessment;
Currently receiving systemic treatment (including phototherapy) for atopic dermatitis or currently on topical treatment, but otherwise candidates for systemic treatment.

Exclusion criteria:

Concurrent participation in an interventional clinical trial which modifies patient care.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Updated on 21 Aug 2025. Study ID: NCT03687359